APA (7th ed.) Citation

J, Z., H, D., E, Q., R, S., AE, G., SM, M., . . . S, P. (2025). CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection. The Journal of clinical investigation, 135(4), . https://doi.org/10.1172/JCI188222

Chicago Style (17th ed.) Citation

J, Zheng, et al. "CXCL12 Ameliorates Neutrophilia and Disease Severity in SARS-CoV-2 Infection." The Journal of Clinical Investigation 135, no. 4 (2025). https://doi.org/10.1172/JCI188222.

MLA (9th ed.) Citation

J, Zheng, et al. "CXCL12 Ameliorates Neutrophilia and Disease Severity in SARS-CoV-2 Infection." The Journal of Clinical Investigation, vol. 135, no. 4, 2025, https://doi.org/10.1172/JCI188222.